Trial intelligence / Profile preview

Terlipressin for early acute kidney injury detection in cirrhotic patients guided by plasma NGAL

PACTR201704002184280Not yet recruiting

Sponsor
Souad Kafafi University Hospital
Start
Apr 2017
Modality
Peptides
Countries
1
01

Overview

Single-arm trial of terlipressin in acute kidney failure (AKF), sponsored by Souad Kafafi University Hospital. Primary endpoint: Early detection of renal dysfunction. Planned start Apr 2017; status: not yet recruiting.

02

Drugs

terlipressin
03

Conditions

acute kidney failure (AKF)

Beyond the preview

Go deeper on PACTR201704002184280.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201704002184280.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call